 Fujifilm Holdings Corp. said Monday it is preparing to manufacture up to 300,000 new courses of treatment of its anti-influenza drug for use in people with Ebola virus disease—the latest sign of the drug industry’s scramble to help contain the widening outbreak.. The Japanese company said it has an inventory of 20,000 courses of treatment of Avigan tablets, plus an additional inventory of active pharmaceutical ingredients to make the 300,000 courses of treatment.